Stay updated on Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Sign up to get notified when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.

Latest updates to the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page
- Check4 days agoChange DetectedThe page now reflects an updated ClinicalTrials.gov interface/version revision (from v3.5.2 to v3.5.3), indicating a platform release rather than a change to the underlying clinical trial record.SummaryDifference0.0%

- Check11 days agoChange DetectedPage history shows Revision: v3.5.2 in place of Revision: v3.5.0.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.5.0 was added to the history, and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page history now lists revision v3.4.3 and removes v3.4.2, reflecting the latest update to the record.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded and updated core trial status fields: Completed as the new Study Status, with Recruitment Status and updated Contacts/Locations. These changes reflect the trial's current operational state and contact information.SummaryDifference0.3%

- Check75 days agoChange DetectedThe page history shows a new Revision: v3.4.2 replacing v3.4.1, a routine maintenance update that does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.